RU-58841 (154992-24-2)
Synonyms: 4-(4,4-Dimethyl-2,5-dioxo-3-(4-hydroxybutyl)1-imidazolidinyl)-2-(trifluoromethyl)benzonitrile; 4-[3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)benzonitrile; 4-[3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-trifluoromethylbenzonitrile; 4-[3-(4-Hydroxybutyl)-4,4-diMethyl-2,5-dioxoiMidazolidin-1-yl]-2-(trifluoroMethyl)benzonitrile; Benzonitrile, 4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)-; RU 58841
Cas No.:154992-24-2
Purity:99%min
Molecular formula: C17H18F3N3O3
EINECS: 1592732-453-0
Appearance: white crystalline powder
Package: 1kg/bag, 5kg/bag, 25kg/drum, 50kg/drum
RU-58841 Cas No.: 154992-24-2 is a non-steroidal anti-androgen compound that acts as a selective androgen receptor modulator (SARM). It is unlike traditional steroidal anti-androgens. And it offers a unique approach to combating hair loss by specifically targeting androgen receptors in the scalp. By blocking the binding of dihydrotestosterone (DHT) – a potent androgen implicated in hair follicle miniaturization. It aims to halt the progression of male pattern baldness and promote hair regrowth.
RU-58841 exerts its effects through competitive inhibition of the androgen receptor. It preventing DHT from exerting its damaging effects on hair follicles. It disrupts the androgen signaling pathway in the scalp. And aims to maintain hair follicle function and viability thereby preserving existing hair and promoting the growth of new hair shafts. This targeted approach offers the potential for localized treatment with minimal systemic side effects. And making it an attractive option for individuals seeking alternatives to conventional hair loss treatments. There is growing optimism surrounding its potential as a novel therapeutic agent for hair loss treatment. And the research into RU-58841 will continue to evolve. With continued innovation and investment in dermatological research, it holds the promise of offering renewed hope to millions of individuals worldwide struggling with hair loss.
RU-58841 represents a significant advancement in the field of hair loss treatment. It offering a targeted and mechanism-based approach to addressing the underlying causes of male pattern baldness. Researchers are continue to explore its therapeutic potential. And it holds the promise of ushering in a new era of personalized and effective solutions for individuals seeking to restore their hair and confidence. With ongoing advancements in science and technology, the future looks promising and the millions of individuals worldwide affected by hair loss.
Certificate of Analysis:
| Item | Index | Test Result |
|---|---|---|
| Appearance | white crystalline powder | white crystalline powder |
| Identification (H-NMR) | positive | conforms |
| Purity (HPLC) | >98% | 99.5% |
| Loss on dry | <0.5% | 0.10% |
| Conclusion | Approved |
| Item No.: | CHL0005 |
|---|---|
| Purity: | 99%min |
| CAS NO.: | 154992-24-2 |